PL48393B1 - - Google Patents

Info

Publication number

PL48393B1

PL48393B1 PL97866A PL9786661A PL48393B1 PL 48393 B1 PL48393 B1 PL 48393B1 PL 97866 A PL97866 A PL 97866A PL 9786661 A PL9786661 A PL 9786661A PL 48393 B1 PL48393 B1 PL 48393B1

Authority

PL

Poland

Prior art keywords

sodium carbonate

acetylsalicylic acid

acidic sodium

acidic

ruch

Prior art date

1961-12-12

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 claims description 2
• 239000000203 mixture Substances 0.000 claims description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 6
• 230000002378 acidificating effect Effects 0.000 claims 3
• 229910000029 sodium carbonate Inorganic materials 0.000 claims 3
• BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 2
• 229960001138 acetylsalicylic acid Drugs 0.000 claims 2
• 230000003020 moisturizing effect Effects 0.000 claims 1
• 239000003960 organic solvent Substances 0.000 claims 1
• 238000002360 preparation method Methods 0.000 claims 1
• 230000001105 regulatory effect Effects 0.000 claims 1
• JZLOKWGVGHYBKD-UHFFFAOYSA-M sodium;2-acetyloxybenzoate Chemical compound [Na+].CC(=O)OC1=CC=CC=C1C([O-])=O JZLOKWGVGHYBKD-UHFFFAOYSA-M 0.000 claims 1
• 238000005406 washing Methods 0.000 claims 1
• 206010036030 Polyarthritis Diseases 0.000 description 3
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
• MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
• MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
• 230000001154 acute effect Effects 0.000 description 2
• 229960004544 cortisone Drugs 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 239000003435 antirheumatic agent Substances 0.000 description 1
• 206010003246 arthritis Diseases 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 239000008119 colloidal silica Substances 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 208000030428 polyarticular arthritis Diseases 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 201000003068 rheumatic fever Diseases 0.000 description 1
• 150000003873 salicylate salts Chemical class 0.000 description 1
• PCTXBFQNMDKOSP-UHFFFAOYSA-M sodium;(2-carboxyphenyl) sulfate Chemical compound [Na+].OS(=O)(=O)OC1=CC=CC=C1C([O-])=O PCTXBFQNMDKOSP-UHFFFAOYSA-M 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1